StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Senti Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Senti Biosciences's price to sales ratio was 29.4× on Oct 31, 2024, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 35.8×, with a median of 10.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 202429.4×+18.2
2023Dec 29, 202311.2×−1.1
2022Dec 30, 202212.3×–

More Senti Biosciences figures

See a number that looks wrong?